Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Platz CoTSE:7813 74 Debt-to-EBITDA is 3.39 as of Mar. 2026, which is 27% below its 10-year median of 4.67. GuruFocus rates TSE:7813 with a GF Score™ of 74/100 and a GF Value™ of 円923.76 (Fairly Valued). The stock has 5 warning signs investors should review. Among 475 Medical Devices & Instruments companies, Platz Co ranks worse than 74.11% on this metric.
Debt-to-EBITDA measures a company's ability to pay off its debt.
A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.
The historical rank and industry rank for Platz Co's Debt-to-EBITDA or its related term are showing as below:
TSE:7813'
s Debt-to-EBITDA Range Over the Past 10 Years
Min: 2.02 Med: 4.67 Max: 7.86
Current: 3.71
During the past 13 years, the highest Debt-to-EBITDA Ratio of Platz Co was 7.86. The lowest was 2.02. And the median was 4.67.
TSE:7813's Debt-to-EBITDA is ranked worse than 74.11% of 475
companies
in the Medical Devices & Instruments industry
Industry Median: 1.63
vs TSE:7813: 3.71
A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.
According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.
Platz Co Debt-to-EBITDA Related Terms
Platz Co Debt-to-EBITDA Historical Data
* Premium members only.
The historical data trend for Platz Co's Debt-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TSE:7813 vs ISRG, BDX, RMD: Debt-to-EBITDA Comparison
For the Medical Instruments & Supplies subindustry, Platz Co's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Platz Co Debt-to-EBITDA vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Platz Co's Debt-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Platz Co's Debt-to-EBITDA falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data,
the EBITDA data used here is four times the quarterly (Mar. 2026) EBITDA data.
Platz Co (TSE:7813) has a Debt-to-EBITDA of 3.39 as of Mar. 2026. Debt-to-EBITDA ratio represents the ratio of total debt to total earnings before interest, taxes, depreciation and amortization. View historical data on Platz Co. This is 27% below median its historical median of 4.67. Over the past decade, Platz Co's Debt-to-EBITDA has ranged from 2.02 to 7.86. According to the industry distribution chart, Platz Co ranks #352 out of 475 companies in the Medical Devices & Instruments industry, placing it in the top 74.1%.
Is Platz Co's Debt-to-EBITDA too high?
Platz Co's current Debt-to-EBITDA of 3.39 is 27% below median its 10-year median of 4.67. Over the past 10 years, this metric has ranged from a low of 2.02 to a high of 7.86. The Medical Devices & Instruments industry median Debt-to-EBITDA is 1.63. Platz Co's value of 3.39 is 108% above this industry median. Based on the distribution chart, Platz Co ranks #352 out of 475 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Platz Co has a GF Score™ of 74/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Platz Co's Debt-to-EBITDA compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Platz Co ranks #352 out of 475 companies for Debt-to-EBITDA. This places Platz Co in the lower half of its industry. The industry median Debt-to-EBITDA is 1.63. Platz Co's value of 3.39 is 108% above this benchmark. Historically, Platz Co's own Debt-to-EBITDA has ranged from 2.02 to 7.86 over the past decade. While the company's 10-year median is 4.67 vs. the industry median of 1.63, Platz Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Debt-to-EBITDA for a Medical Devices & Instruments company?
The median Debt-to-EBITDA among Medical Devices & Instruments companies is 1.63, based on 475 companies in the industry. Companies in the top quartile (top 25%) have a Debt-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, Debt-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Platz Co's current Debt-to-EBITDA of 3.39 is 108% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Debt-to-EBITDA mean?
A high Debt-to-EBITDA can signal that a stock is expensive relative to its fundamentals. Debt-to-EBITDA ratio represents the ratio of total debt to total earnings before interest, taxes, depreciation and amortization. View historical data on Platz Co. For the Medical Devices & Instruments industry, the median Debt-to-EBITDA is 1.63 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Platz Co's current Debt-to-EBITDA is 3.39, which is 27% below median its own 10-year median of 4.67. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Platz Co stock overvalued right now?
Based on GuruFocus' analysis, Platz Co (TSE:7813) is currently considered Fairly Valued. The stock's GF Value™ is 円923.76, compared to a current price of 円878.00 — trading 5% below its estimated fair value. The current Debt-to-EBITDA is 3.39, which is 27% below median its 10-year median of 4.67 and 108% above the Medical Devices & Instruments industry median of 1.63. Platz Co's overall GF Score™ is 74/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Debt-to-EBITDA calculated?
Debt-to-EBITDA is calculated from a company's financial statements. For Platz Co (TSE:7813), the current Debt-to-EBITDA is 3.39 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Platz Co (TSE:7813) Overvalued in 2026?
Based on GuruFocus' analysis, Platz Co stock appears to be undervalued.
The current stock price of 円878.00 is trading 5% below its estimated GF Value™ of 円923.76.
GuruFocus considers Platz Co to be Fairly Valued.
Key valuation signals for TSE:7813:
Debt-to-EBITDA: 3.39 (27% below median its 10-year median of 4.67)
GF Value™: 円923.76 vs. price of 円878.00 (5% below fair value)
Industry Position: 108% above the Medical Devices & Instruments median (#352 of 475)
No single metric tells the full story. See the TSE:7813 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Platz Co Ltd is engaged in the manufacturing and sales of nursing care beds, mattresses, and other bed-related items. The company's products include nursing care beds, hospital beds, care facility beds, reclining beds, and accessories.
74GF Score
Get the complete analysis for TSE:7813
Debt-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:7813 has been successfully added to your 
